We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMPQ
6676
DELISTED
Umpqua Holdings Corp
UMPQ
-6,838
Closed -$122K
RFP
6677
DELISTED
Resolute Forest Products Inc.
RFP
-731
Closed -$15.8K
ELVT
6678
DELISTED
Elevate Credit, Inc.
ELVT
-7,584
Closed -$13.8K
COUP
6679
DELISTED
Coupa Software Incorporated
COUP
-9,134
Closed -$723K
ABGI
6680
DELISTED
ABG Acquisition Corp. I
ABGI
-167
Closed -$1.69K
IRL
6681
DELISTED
NEW IRELAND FUND INC
IRL
-100
Closed -$1K
CINC
6682
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
-5,807
Closed -$71K
DCRD
6683
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
-291
Closed -$3K
CPAQ
6684
DELISTED
Counter Press Acquisition Corporation Class A Ordinary Share
CPAQ
-31
Closed
FTAAU
6685
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
-393
Closed -$4K
ZGN.WS
6686
DELISTED
Ermenegildo Zegna N.V. Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
ZGN.WS
-50
Closed -$146
ONEM
6687
DELISTED
1Life Healthcare
ONEM
-7,621
Closed -$127K
PAYA
6688
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
-729
Closed -$6K
LHCG
6689
DELISTED
LHC Group LLC
LHCG
-5,743
Closed -$929K
WEBR
6690
DELISTED
Weber Inc.
WEBR
-2,237
Closed -$18K
LGACU
6691
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
-380
Closed -$4K
MCAE
6692
DELISTED
Mountain Crest Acquisition Corp. III Common Stock
MCAE
-8
Closed
CHAD
6693
DELISTED
Direxion Daily CSI 300 China A Share Bear 1X Shares
CHAD
-7
Closed
MSAC
6694
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
-1,312
Closed -$13K
AVYA
6695
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$0 ﹤0.01%
68
-22,211
-100% -$6.52K
CENQU
6696
DELISTED
CENAQ Energy Corp. Unit
CENQU
-2
Closed
PTNR
6697
DELISTED
Partner Communications
PTNR
-49
Closed
ITQ
6698
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
-1
Closed
ATNX
6699
DELISTED
Athenex, Inc. Common Stock
ATNX
$0 ﹤0.01%
61
+56
+1,120% +$166
VLDR
6700
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-14,377
Closed -$10K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.